Stay updated with breaking news from Bobt Li. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Updated safety data supports the selection of 20 mg/kg q2w as the recommended Phase 2 dose Improved efficacy with one partial response improving to a complete response , two additional patients with...
Fam-trastuzumab deruxtecan-nxki elicited responses that proved to be durable in patients with a range of solid tumors harboring HER2 mutations.
China’s rise to the world’s second-largest economy has led to a big increase in philanthropy in the country.
NEW YORK – Sept. 19, 2023 – Forbes China today announced its fourth Forbes China Healthcare Summit will take place virtually on Sept. 22, 2023 in the U.S. (Sept. 23, 2...
Bob T. Li, MD, PhD, MPH, discusses the results of a phase 1/2 study of the first-in-class immune-stimulating antibody conjugate BDC-1001 in patients with advanced HER2-expressing solid tumors.